Latest news
Applied Biologics Gains IRB Approval for Phase 3 BIOxHEAL Trial in Diabetic Foot Ulcers - BioPharm InternationalBioPharm International · Wed, 05 Aug 2026 21:15:33 GMTHengrui Eyes Fresh NDA For Mounjaro Rival After Second Phase III Diabetes Win - insights.citeline.cominsights.citeline.com · Wed, 05 Aug 2026 08:11:52 GMT